Telephone-Delivered Exercise for Multiple Sclerosis Fatigue
Telephone-Delivered Interventions to Target Multiple Sclerosis Fatigue
What it found
Results are posted in the registry, but without a statistical test of the main measure. See the numbers below.
What was tested
Treatment tested
- Telephone-Delivered Exercise Therapy
Compared with
- In-Person Delivered Exercise Therapy
Results by group
Daily Average Fatigue Intensity Score
Baseline (pre) and 8 weeks (post)
| Group | Value | Interval | Number analysed |
|---|---|---|---|
| In-Person Delivered Exercise | 3.9 units on a scale | 1.9 (Standard Deviation) | 9 |
| Telephone-Delivered Exercise | 4.4 units on a scale | 1.1 (Standard Deviation) | 10 |
| In-Person Delivered Exercise | 3.2 units on a scale | 1.9 (Standard Deviation) | 9 |
| Telephone-Delivered Exercise | 2.3 units on a scale | 1.5 (Standard Deviation) | 10 |
In-Person Delivered Exercise
Telephone-Delivered Exercise
In-Person Delivered Exercise
Telephone-Delivered Exercise
Daily Average Fatigue Interference Score
Baseline (pre) and 8 weeks (post)
| Group | Value | Interval | Number analysed |
|---|---|---|---|
| In-Person Delivered Exercise | 3.1 units on a scale | 1.9 (Standard Deviation) | 9 |
| Telephone-Delivered Exercise | 3.0 units on a scale | 1.3 (Standard Deviation) | 10 |
| In-Person Delivered Exercise | 2.7 units on a scale | 1.8 (Standard Deviation) | 9 |
| Telephone-Delivered Exercise | 1.5 units on a scale | 1.7 (Standard Deviation) | 10 |
In-Person Delivered Exercise
Telephone-Delivered Exercise
In-Person Delivered Exercise
Telephone-Delivered Exercise
Values as posted on ClinicalTrials.gov. Outcomes measured differently across trials are not directly comparable.
Safety
| Group | Participants at risk | Serious adverse events | Deaths |
|---|---|---|---|
| In-Person Delivered Exercise | 10 | 0 (0.0%) | 0 |
| Telephone-Delivered Exercise | 10 | 0 (0.0%) | 0 |
As posted on ClinicalTrials.gov. Serious adverse events include any serious health event during the trial, whether or not the treatment caused it.
What it measured
Main measures
Daily Average Fatigue Intensity Score
Baseline (pre) and 8 weeks (post)
FatigueDaily Average Fatigue Interference Score
Baseline (pre) and 8 weeks (post)
Fatigue
Who could take part
Relapsing and progressive · 18 and over
Show the full criteria
Inclusion criteria
* Diagnosis of RRMS, SPMS, or PPMS * Ambulatory for at least 5 minutes at a time * Self-reported fatigue on Fatigue Severity Scale * Able to follow study-related commands * Able to attend study appointments
Exclusion criteria
* MS exacerbation within the past 30 days * Evidence of another neurological disorder or orthopedic disorder that would interfere with exercise participation * Acute illness or injury that prevents participation in the intervention * Pregnancy
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
Multiple sclerosis (MS) is a progressive demyelinating disorder that damages white matter in the central nervous system. Although individuals experience mobility (e.g., walking, balance) impairments that lower quality of life and limit participation in daily activities, one of the most prominent symptoms is fatigue. Up to 92% of individuals report fatigue that manifests as lack of energy, exhaustion or worsening of MS symptoms and ultimately contributes to increasing disability. The currently available pharmaceutical treatments fail to fully control fatigue in the majority of individuals with MS; non-pharmacologic therapies such as exercise and behavioral therapies offer the best hope for combating MS fatigue in the majority of individuals. Exercise therapy is effective in reducing MS fatigue. However, access to exercise therapy is seriously limited for many individuals with MS due to geographical location, limited resources (e.g., financial, transportation), and/or disability. Thus, the development and evaluation of an alternative delivery method for exercise therapy to target MS-related fatigue that increases participation and reduces barriers is critical. In this study, the investigators will compare traditional in-person delivered exercise therapy to telephone-delivered exercise therapy to target fatigue in persons with MS.
Papers
Loading reviews and guidelines…
History
Started
Jun 2017
Main results due
May 2018
Finished
Jul 2018
Results posted
Oct 2019